SSKN
STRATA Skin Sciences, Inc.Company Information
- Company Name
- STRATA Skin Sciences, Inc.
- CIK
- CIK0001051514
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SSKN: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SSKN
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-18
- Last sale
- 2025-11-17
- Shares purchased (TTM)
- 5,000
- Shares sold (TTM)
- 14,094
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 1,090,274
- Shares outstanding
- 4,650,556
- Ownership
- 23.44%
Earnings Market Reaction
- Filing date
- 2026-03-26
- Price on filing date
- —
- 1-month reaction
- -32.05%
- 3-month reaction
- -51.64%
Balance Sheet
Values in millions ($)| Line item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 7 | 6 | 7 | 7 | 7 | 5 | 5 | 7 | 7 | 9 | 3 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | ||||||
| Inventory Net | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 6 | 6 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Assets Current | 16 | 14 | 14 | 16 | 17 | 16 | 14 | 13 | 16 | 20 | 21 | 15 | ||||||
| Property Plant And Equipment Net | 9 | 10 | 9 | 9 | 10 | 10 | 11 | 12 | 12 | 8 | 8 | 8 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 10 | 16 | 17 | ||||||
| Goodwill | 1 | 1 | 3 | 3 | 1 | 6 | 7 | 7 | 7 | 9 | 9 | 9 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 31 | 31 | 31 | 34 | 35 | 39 | 40 | 40 | 42 | 47 | 55 | 49 | ||||||
Liabilities Current | ||||||||||||||||||
| Long Term Debt Current | 15 | 2 | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Accounts Payable Current | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 4 | 3 | 3 | 4 | 3 | ||||||
| Accrued Liabilities Current | 6 | 6 | 7 | 9 | 7 | 8 | 7 | 6 | 6 | 6 | 7 | 7 | ||||||
| Contract With Customer Liability Current | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Liabilities Current | 27 | 15 | 14 | 15 | 13 | 13 | 12 | 13 | 12 | 12 | 14 | 13 | ||||||
| Long Term Debt Noncurrent | 0 | 13 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 8 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities And Deferred Revenue Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 8 | 8 | ||||||
| Liabilities | 28 | 29 | 30 | 32 | 30 | 30 | 30 | 31 | 29 | 31 | 38 | 30 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 257 | 256 | 253 | 253 | 253 | 253 | 251 | 251 | 251 | 250 | 250 | 249 | ||||||
| Retained Earnings Accumulated Deficit | -254 | -254 | -253 | -251 | -248 | -244 | -242 | -241 | -238 | -234 | -233 | -230 | ||||||
| Stockholders Equity | 3 | 1 | 0 | 3 | 5 | 9 | 9 | 9 | 13 | 16 | 17 | 19 | ||||||
| Liabilities And Stockholders Equity | 31 | 31 | 31 | 34 | 35 | 39 | 40 | 40 | 42 | 47 | 55 | 49 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 6 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | ||||||
| Shares Outstanding | 6 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSTRATA Skin Sciences, Inc. (SSKN) — SEC Financial Statements & Analysis
STRATA Skin Sciences, Inc. (SSKN) is a surgical & medical instruments & apparatus company, incorporated in DE. STRATA Skin Sciences, Inc. trades on OTC as: SSKN. STRATA Skin Sciences, Inc. (SSKN)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-03-26. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), STRATA Skin Sciences, Inc. carries a market cap of $5.86M, a P/E ratio of -0.94x, a P/B ratio of 2.02x, a P/S ratio of 0.19x, an enterprise value of $13.30M, and an EV/EBITDA multiple of -23.04x. On profitability, it posts a gross margin of 58.25%, an operating margin of -15.31%, a net margin of -20.40%, a Return on Equity (ROE) of -158.91%, a Return on Assets (ROA) of -19.13%, and a Return on Invested Capital (ROIC) of -40.52%. Per share, it reports EPS of $-1.35, diluted EPS of $-1.35, free cash flow per share of $-0.94, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -8.54% year-over-year, net income growth of -37.92% year-over-year, and EPS growth of -49.18% year-over-year. On the balance sheet, it maintains a current ratio of 0.58x, a quick ratio of 0.45x, working capital of $-11.14M, a debt-to-equity ratio of 9.50x, a debt ratio of 0.9, an interest coverage ratio of -2.40x, free cash flow of $-4.38M (TTM), and net debt of $7.44M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.86M
- P/E TTM
- -0.94x
- EPS TTM
- $-1.35
- P/B TTM
- 2.02x
- ROE TTM
- -158.91%
- ROA TTM
- -19.13%
- Debt To Equity
- 9.50x
- Free Cash Flow TTM
- $-4.38M
- Net Revenue TTM Growth 1Y
- -8.54%
Data as of 2025-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is STRATA Skin Sciences, Inc. in?
STRATA Skin Sciences, Inc. (SSKN) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SSKN trade on?
STRATA Skin Sciences, Inc. (SSKN) trades on the OTC.
Where is STRATA Skin Sciences, Inc. incorporated?
STRATA Skin Sciences, Inc. is incorporated in DE.
When was STRATA Skin Sciences, Inc. (SSKN)'s most recent SEC filing?
STRATA Skin Sciences, Inc. (SSKN)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-03-26.
What is SSKN's market cap?
STRATA Skin Sciences, Inc. (SSKN) has a market capitalization of $5.86M as of 2025-12-31.
What is SSKN's EPS (earnings per share)?
STRATA Skin Sciences, Inc. (SSKN)'s trailing twelve month EPS is $-1.35 as of 2025-12-31.
What is SSKN's ROE (return on equity)?
STRATA Skin Sciences, Inc. (SSKN)'s trailing twelve month Return on Equity (ROE) is -158.91% as of 2025-12-31.
What is SSKN's ROA (return on assets)?
STRATA Skin Sciences, Inc. (SSKN)'s trailing twelve month Return on Assets (ROA) is -19.13% as of 2025-12-31.
What is SSKN's ROIC (return on invested capital)?
STRATA Skin Sciences, Inc. (SSKN)'s trailing twelve month Return on Invested Capital (ROIC) is -40.52% as of 2025-12-31.
What is SSKN's EV/EBITDA?
STRATA Skin Sciences, Inc. (SSKN)'s trailing twelve month EV/EBITDA is -23.04x as of 2025-12-31.